ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 65 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,666,000 | -6.3% | 1,765,031 | +0.8% | 0.00% | – |
| Q2 2021 | $9,250,000 | +12.2% | 1,751,820 | +2.0% | 0.00% | – |
| Q1 2021 | $8,244,000 | +95.5% | 1,717,484 | +76.4% | 0.00% | – |
| Q4 2020 | $4,216,000 | +9.9% | 973,612 | +4.6% | 0.00% | – |
| Q3 2020 | $3,836,000 | +60.9% | 931,142 | 0.0% | 0.00% | – |
| Q2 2020 | $2,384,000 | -15.8% | 931,142 | -4.9% | 0.00% | – |
| Q1 2020 | $2,830,000 | -20.6% | 979,428 | +4.1% | 0.00% | – |
| Q4 2019 | $3,566,000 | -27.9% | 940,829 | -2.7% | 0.00% | – |
| Q3 2019 | $4,945,000 | -22.6% | 966,724 | -6.2% | 0.00% | – |
| Q2 2019 | $6,392,000 | -29.7% | 1,030,964 | -19.4% | 0.00% | – |
| Q1 2019 | $9,094,000 | +3.0% | 1,279,011 | +23.8% | 0.00% | – |
| Q4 2018 | $8,827,000 | -56.3% | 1,033,537 | +2.5% | 0.00% | -100.0% |
| Q3 2018 | $20,189,000 | -21.0% | 1,008,448 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $25,560,000 | +14.2% | 989,569 | +5.7% | 0.00% | 0.0% |
| Q1 2018 | $22,382,000 | -9.0% | 936,505 | +29.0% | 0.00% | 0.0% |
| Q4 2017 | $24,606,000 | +64.3% | 726,042 | +2.6% | 0.00% | 0.0% |
| Q3 2017 | $14,975,000 | +14.9% | 707,370 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $13,034,000 | +4.0% | 745,237 | +4.0% | 0.00% | 0.0% |
| Q1 2017 | $12,537,000 | +14.2% | 716,419 | +10.3% | 0.00% | 0.0% |
| Q4 2016 | $10,978,000 | +7.2% | 649,594 | +4.1% | 0.00% | 0.0% |
| Q3 2016 | $10,237,000 | +9.3% | 623,838 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $9,369,000 | +30.1% | 618,782 | +24.3% | 0.00% | – |
| Q1 2016 | $7,199,000 | -16.6% | 497,870 | +63.4% | 0.00% | -100.0% |
| Q4 2015 | $8,628,000 | -95.6% | 304,694 | -94.0% | 0.00% | -85.7% |
| Q3 2015 | $194,783,000 | +4355.2% | 5,099,524 | +2958.3% | 0.01% | – |
| Q2 2015 | $4,372,000 | +67.6% | 166,742 | +11.8% | 0.00% | – |
| Q1 2015 | $2,609,000 | +51.3% | 149,161 | +50.2% | 0.00% | – |
| Q4 2014 | $1,724,000 | +140.8% | 99,277 | +158.4% | 0.00% | – |
| Q3 2014 | $716,000 | +138.7% | 38,420 | +133.9% | 0.00% | – |
| Q2 2014 | $300,000 | – | 16,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |